Duke University Medical Center, Durham, NC 27710, USA.
J Thorac Cardiovasc Surg. 2011 Jan;141(1):98-106.e1-2. doi: 10.1016/j.jtcvs.2010.09.016.
Operation for infective endocarditis is associated with the highest mortality of any valve disease, with overall rates of in-hospital mortality exceeding 20%. The Society of Thoracic Surgeons Adult Cardiac Surgery Database was examined to develop a simple risk scoring system and identify areas for quality improvement.
From 2002 through 2008, 19,543 operations were performed for infective endocarditis. Logistic regression analysis related baseline characteristics to both operative mortality and a composite of mortality and major morbidity within 30 days. Points were assigned to each risk factor, and estimated risk was obtained by averaging events for all patients having the same number of points.
Overall unadjusted mortality was 8.2%, and complications occurred in 53%. Significant preoperative risk factors for mortality (associated points) were as follows: emergency, salvage status, or cardiogenic shock (17), preoperative hemodialysis, renal failure, or creatinine level less than 2.0 (12), preoperative inotropic or balloon pump support (10), active (vs treated) endocarditis (10), multiple valve involvement (9), insulin-dependent diabetes (8), arrhythmia (8), previous cardiac surgery (7), urgent status without cardiogenic shock (6), non-insulin-dependent diabetes (6), hypertension (5), and chronic lung disease (5), with a C statistic of 0.7578 (all P < .001). Risk-adjusted mortality and major morbidity were unchanged over the course of the study. In the entire data set, mortality was better if "any valve" was repaired (odds ratio = 0.76; P = .0023).
Operative mortality for surgically treated infective endocarditis is substantially lower than reported in-hospital mortality rates for infective endocarditis. The described risk scoring system will inform clinical decision-making in these complex patients.
感染性心内膜炎的手术治疗与任何瓣膜疾病相关的死亡率最高,住院死亡率超过 20%。本研究通过检查胸外科医师协会成人心脏手术数据库,旨在开发一种简单的风险评分系统,并确定质量改进的领域。
2002 年至 2008 年间,共有 19543 例感染性心内膜炎患者接受手术治疗。逻辑回归分析将基线特征与手术死亡率以及术后 30 天内死亡率和主要发病率的复合事件相关联。为每个危险因素分配分值,通过将所有具有相同分数的患者的事件平均来获得估计风险。
总体未调整死亡率为 8.2%,并发症发生率为 53%。死亡率的显著术前危险因素(相关分值)如下:紧急情况、抢救状态或心源性休克(17 分)、术前血液透析、肾衰竭或肌酐水平<2.0(12 分)、术前正性肌力或球囊泵支持(10 分)、活动期(而非治疗期)心内膜炎(10 分)、多瓣膜受累(9 分)、胰岛素依赖型糖尿病(8 分)、心律失常(8 分)、既往心脏手术史(7 分)、无心源性休克的紧急情况(6 分)、非胰岛素依赖型糖尿病(6 分)、高血压(5 分)和慢性肺部疾病(5 分),C 统计量为 0.7578(所有 P<0.001)。研究过程中,风险调整后的死亡率和主要发病率保持不变。在整个数据集,与住院死亡率相比,任何瓣膜修复(比值比=0.76;P=0.0023)可降低死亡率。
手术治疗感染性心内膜炎的手术死亡率明显低于报道的感染性心内膜炎住院死亡率。描述的风险评分系统将为这些复杂患者的临床决策提供信息。